SlideShare a Scribd company logo
HYPERKALEMIA
Presenter: Dr. Nikhil
DEFINITION
 It is defined as a serum potassium concentration greater than
5.5mEq/L.
 The normal serum concentration range for potassium is 3.5-
5.0mEq/L
CAUSES OF HYPERKALEMIA :
I. Pseudohyperkalemia
II. Intra- to extracellular shift
III. Inadequate excretion
I. Pseudohyperkalemia
• Factitious hyperkalemia
•Artifactual increase in serum K+ due to the release of K+ during or after
venipuncture.
• Causes :
(a) In-vitro hemolysis.
(b) Marked leukocytosis or thrombocytosis
II. Intra- to extracellular shift
A. Acidosis
B. Hypertonicity
C. Digoxin and related glycosides (yellow oleander)
D. Succinylcholine; thermal trauma, neuromuscular injury, disuse
atrophy, mucositis, or prolonged immobilization
E. Rapid tumor lysis
(A) ACIDOSIS :
Acidemia → cellular uptake of H+ → efflux of K+
(B) HYPEROSMOLALITY
- Due to osmotic gradient ("solvent drag" effect)
-Hyperkalemia due to hypertonic mannitol, hypertonic saline, and
intravenous immune globulin is due to osmotic gradient.
-Diabetics are also prone to osmotic hyperkalemia in response to
intravenous hypertonic glucose, when given without adequate insulin.
(C) DIGOXIN
• Digoxin → inhibits Na+/K+-ATPase → impairs uptake of K+ so, digoxin
overdose → hyperkalemia.
• Structurally related glycosides found in yellow oleander or foxglove
• (D) SUCCINYLCHOLINE
• SCh → depolarizes muscle cells→ efflux of K+ through
acetylcholine receptors (AChRs).
• Contraindicated in patients who have sustained thermal
trauma, neuromuscular injury, disuse atrophy, mucositis, or
prolonged immobilization because it leads to an exaggerated
efflux of K+ causing acute hyperkalaemia.
(F) EXCESS INTAKE OR TISSUE NECROSIS
Following conditions provoke severe hyperkalemia in
susceptible patients :
Foods rich in potassium include tomatoes, bananas, and citrus
fruits;
 Red cell transfusion, typically massive transfusions.
Finally, severe tissue necrosis, as in acute tumor lysis
syndrome and rhabdomyolysis.
• III. Inadequate excretion
A.Inhibition of RAAS; ↑ risk of hyperkalemia when used in combination :
 ACE inhibitors, ARBs, Mineralocorticoidreceptor
blockers, Blockade of the ENaC
B. Decreased distal delivery eg., CHF
C. Hyporeninemic hypoaldosteronism
1. Tubulointerstitial diseases: SLE, sickle cell anemia
2. Diabetes, diabetic nephropathy
3. Drugs: NSAIDs, β-blockers, cyclosporine
4. Chronic kidney disease, advanced age
D. Advanced renal insufficiency eg., CKD, ESRD
E. Primary adrenal insufficiency
1. Autoimmune: Addison’s disease
2. Infectious: HIV, CMV, TB
3. Infiltrative: amyloidosis, malignancy
4. Drug-associated: heparin, LMWH
5. Hereditary: adrenal hypoplasia congenita
CLINICAL FEATURES
-Medical emergency due to its effects on heart, i.e., cardiac
arrhythmias.
 Most of Hyperkalemic individuals are asymptomatic.
 If present- symptoms are nonspecific and predominantly related to
muscular or cardiac functions.
 The most common - weakness and fatigue.
 Occasionally,frank muscle paralysis or shortness of breath.
 Patients also may complain of palpitations or chest pain.
 Arrythmias occur- Sinus Brady, Sinus arrest, VT, VF,
Asystole
 Patients may report nausea, vomiting, and paresthesias
DIAGNOSTIC APPROACH
•First priority is to assess the need for emergency treatment, followed
by a comprehensive workup to determine the cause.
Hyperkalemia final
Trans-tubular potassium gradient (TTKG) :
- index reflecting the conservation of potassium in the cortical
collecting ducts (CCD) of the kidneys.
ECG
TREATMENT :
The treatment of hyperkalemia is divided into three stages:
1.Immediate antagonism of the cardiac effects of hyperkalemia
- Intravenous calcium
2.Rapid reduction in plasma K+ concentration by redistribution
into cells
• Insulin
• β2-agonists (most commonly albuterol)
3. Removal of potassium
- using cation exchange resins, diuretics, and/or dialysis.
- Hemodialysis is the most effective and reliable method to reduce
plasma K+ concentration.
Hyperkalemia final
Hyperkalemia final
Hyperkalemia final
Drugs Dosage ONSET
Length of MOA
effect
Cautions
Ca2+
gluconate
10 mL of
10% solution
IV over 10
minutes
Immediate 30 minutes
from toxic
effects of
Ca2+
Protects Can worsen
myocardium digoxin
toxicity
Insulin Regular
insulin 10
units IV with
50 mL of
50% glucose
15-30
minutes
2-6 hrs. Shifts K+ out
of the
vascular
space and
into the cells
Consider 5% Dextrose solution infusion at 100 mL/hr to prevent hypoglycemia
with repeated doses. Glucose unnecessary if blood sugar elevated above
250mg/dL
Albuterol
(Ventolin)
10-20 mg by
nebulizer
over 10
minutes (use
conc. form,
5mg/mL)
15-30 2-3 hrs.
minutes
Shifts K+
into the
cells,
additive to
the effect of
insulin
May cause a
brief initial
rise in
serum
potassium
Drugs Dosage Onset Length of
effect
MOA Cautions
Furosemide
(Lasix)
20-40 mg IV,
give with
saline if
volume
depletion is a
15 min. - 1
hr.
4 hrs. Increases
renal
excretion of
potassium
Only
effective if
adequate
renal
response to
concern loop diuretic
Sodium
polystyrene
sulfonate
(Kayexalate)
Oral : 50 g in
30 mL of
sorbitol
solution
Rectal : 50 g
in a retention
1-2 hrs.
(Rectal
route is
faster)
4-6 hrs. Removes
potassium
from the gut
in exchange
for sodium
Sorbitol may
be
associated
with Bowel
necrosis.
enema
Hyperkalemia final
Hyperkalemia final
THANK YOU

More Related Content

PPTX
Hyperkalemia pathophysiology and treatment
PPTX
Hyperkalemia
PPTX
Hyperkalemia
PPTX
Hypokalemia in ICU
PPTX
Hyperkalemia
PPTX
hypokalemia, diagnosis and management
PPTX
Potassium disorders , comprehensive & practical approach .
PPTX
Hyperkalemia
Hyperkalemia pathophysiology and treatment
Hyperkalemia
Hyperkalemia
Hypokalemia in ICU
Hyperkalemia
hypokalemia, diagnosis and management
Potassium disorders , comprehensive & practical approach .
Hyperkalemia

What's hot (20)

PPTX
ACUTE MANAGEMENT OF Hyperkalemia
PPTX
Hyponatremia (1)
PPTX
Hypomagnesemia
PDF
Hyperkalemia
PPTX
Hypokalemia
PPTX
Diagnosis and management of Hyperkalemia
PPTX
Hypokalemia - Approach and Management
PPTX
Hyperkalemia 160108171542
PPTX
Hypercalcemia and hypocalcemia dr bikal
PDF
Hypocalcemia
PPTX
Approach to management of Hyperkalemia
PPTX
Acute Kidney Injury
PPTX
Hypocalcemia
PPTX
Hyponatremia
PPT
Electrolyte imbalance potassium
PPTX
Hyper magnaesemia
PPTX
Hypokalemia
PPTX
Hyperkalemia
PPTX
Potassium; Hypokalemia and hyperkalemia
PDF
Anemia in ckd patients
ACUTE MANAGEMENT OF Hyperkalemia
Hyponatremia (1)
Hypomagnesemia
Hyperkalemia
Hypokalemia
Diagnosis and management of Hyperkalemia
Hypokalemia - Approach and Management
Hyperkalemia 160108171542
Hypercalcemia and hypocalcemia dr bikal
Hypocalcemia
Approach to management of Hyperkalemia
Acute Kidney Injury
Hypocalcemia
Hyponatremia
Electrolyte imbalance potassium
Hyper magnaesemia
Hypokalemia
Hyperkalemia
Potassium; Hypokalemia and hyperkalemia
Anemia in ckd patients
Ad

Similar to Hyperkalemia final (20)

PDF
Hyperkalemia ppt.pdf
PDF
hyperkalemia-160108171542.pdf
PPTX
hyperkaleimia-GJUnursing susghsgshg.pptx
PPTX
hyperkaleimia-170729063610hgvggffyfc.pptx
PPTX
Presentation About Potassium Imbalance with Causes,Management, Types
PPT
hypertension End Organ Damage with hemorhage
PPT
Hyperkalemia clinical manifestations and
PDF
Hyperkalemia - An overview : Causes and management
PPTX
Pottasium disorders and its management in a nutshellll
PPTX
Pottasium disorders management and evaluation
PPTX
Hypokelemia and hyperkelemia
PPTX
Hyperkalemia
PPTX
SERUM P0TASSIUM IMBALANCES DIAGNOSIS.pptx
PPTX
Potassium disorders-hypokalemia and hyperkalemia
PPTX
Hyperkalemia harrison based concepts theory
PPTX
Clinical approach to patient with Hyperkalemia
PPTX
hyperkalemia, causes and its management.pptx
PPTX
hyperkalamia
PPTX
Hyperkalemia and its management IN children.pptx
PPTX
Hyperkalemia
Hyperkalemia ppt.pdf
hyperkalemia-160108171542.pdf
hyperkaleimia-GJUnursing susghsgshg.pptx
hyperkaleimia-170729063610hgvggffyfc.pptx
Presentation About Potassium Imbalance with Causes,Management, Types
hypertension End Organ Damage with hemorhage
Hyperkalemia clinical manifestations and
Hyperkalemia - An overview : Causes and management
Pottasium disorders and its management in a nutshellll
Pottasium disorders management and evaluation
Hypokelemia and hyperkelemia
Hyperkalemia
SERUM P0TASSIUM IMBALANCES DIAGNOSIS.pptx
Potassium disorders-hypokalemia and hyperkalemia
Hyperkalemia harrison based concepts theory
Clinical approach to patient with Hyperkalemia
hyperkalemia, causes and its management.pptx
hyperkalamia
Hyperkalemia and its management IN children.pptx
Hyperkalemia
Ad

Recently uploaded (20)

PPTX
Neuropathic pain.ppt treatment managment
PPTX
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PDF
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
PPTX
2 neonat neotnatology dr hussein neonatologist
PDF
Cardiology Pearls for Primary Care Providers
PPTX
Cardiovascular - antihypertensive medical backgrounds
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPTX
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
PPTX
obstructive neonatal jaundice.pptx yes it is
PPTX
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPT
Infections Member of Royal College of Physicians.ppt
PPT
Rheumatology Member of Royal College of Physicians.ppt
PDF
TISSUE LECTURE (anatomy and physiology )
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
antibiotics rational use of antibiotics.pptx
PPTX
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
PPTX
the psycho-oncology for psychiatrists pptx
PPTX
Morphology of Bacterial Cell for bsc sud
Neuropathic pain.ppt treatment managment
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
2 neonat neotnatology dr hussein neonatologist
Cardiology Pearls for Primary Care Providers
Cardiovascular - antihypertensive medical backgrounds
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
obstructive neonatal jaundice.pptx yes it is
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
Infections Member of Royal College of Physicians.ppt
Rheumatology Member of Royal College of Physicians.ppt
TISSUE LECTURE (anatomy and physiology )
neurology Member of Royal College of Physicians (MRCP).ppt
antibiotics rational use of antibiotics.pptx
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
the psycho-oncology for psychiatrists pptx
Morphology of Bacterial Cell for bsc sud

Hyperkalemia final

  • 2. DEFINITION  It is defined as a serum potassium concentration greater than 5.5mEq/L.  The normal serum concentration range for potassium is 3.5- 5.0mEq/L
  • 3. CAUSES OF HYPERKALEMIA : I. Pseudohyperkalemia II. Intra- to extracellular shift III. Inadequate excretion
  • 4. I. Pseudohyperkalemia • Factitious hyperkalemia •Artifactual increase in serum K+ due to the release of K+ during or after venipuncture. • Causes : (a) In-vitro hemolysis. (b) Marked leukocytosis or thrombocytosis
  • 5. II. Intra- to extracellular shift A. Acidosis B. Hypertonicity C. Digoxin and related glycosides (yellow oleander) D. Succinylcholine; thermal trauma, neuromuscular injury, disuse atrophy, mucositis, or prolonged immobilization E. Rapid tumor lysis
  • 6. (A) ACIDOSIS : Acidemia → cellular uptake of H+ → efflux of K+ (B) HYPEROSMOLALITY - Due to osmotic gradient ("solvent drag" effect) -Hyperkalemia due to hypertonic mannitol, hypertonic saline, and intravenous immune globulin is due to osmotic gradient. -Diabetics are also prone to osmotic hyperkalemia in response to intravenous hypertonic glucose, when given without adequate insulin.
  • 7. (C) DIGOXIN • Digoxin → inhibits Na+/K+-ATPase → impairs uptake of K+ so, digoxin overdose → hyperkalemia. • Structurally related glycosides found in yellow oleander or foxglove
  • 8. • (D) SUCCINYLCHOLINE • SCh → depolarizes muscle cells→ efflux of K+ through acetylcholine receptors (AChRs). • Contraindicated in patients who have sustained thermal trauma, neuromuscular injury, disuse atrophy, mucositis, or prolonged immobilization because it leads to an exaggerated efflux of K+ causing acute hyperkalaemia.
  • 9. (F) EXCESS INTAKE OR TISSUE NECROSIS Following conditions provoke severe hyperkalemia in susceptible patients : Foods rich in potassium include tomatoes, bananas, and citrus fruits;  Red cell transfusion, typically massive transfusions. Finally, severe tissue necrosis, as in acute tumor lysis syndrome and rhabdomyolysis.
  • 10. • III. Inadequate excretion A.Inhibition of RAAS; ↑ risk of hyperkalemia when used in combination :  ACE inhibitors, ARBs, Mineralocorticoidreceptor blockers, Blockade of the ENaC B. Decreased distal delivery eg., CHF C. Hyporeninemic hypoaldosteronism 1. Tubulointerstitial diseases: SLE, sickle cell anemia 2. Diabetes, diabetic nephropathy 3. Drugs: NSAIDs, β-blockers, cyclosporine 4. Chronic kidney disease, advanced age
  • 11. D. Advanced renal insufficiency eg., CKD, ESRD E. Primary adrenal insufficiency 1. Autoimmune: Addison’s disease 2. Infectious: HIV, CMV, TB 3. Infiltrative: amyloidosis, malignancy 4. Drug-associated: heparin, LMWH 5. Hereditary: adrenal hypoplasia congenita
  • 12. CLINICAL FEATURES -Medical emergency due to its effects on heart, i.e., cardiac arrhythmias.  Most of Hyperkalemic individuals are asymptomatic.  If present- symptoms are nonspecific and predominantly related to muscular or cardiac functions.  The most common - weakness and fatigue.  Occasionally,frank muscle paralysis or shortness of breath.  Patients also may complain of palpitations or chest pain.  Arrythmias occur- Sinus Brady, Sinus arrest, VT, VF, Asystole  Patients may report nausea, vomiting, and paresthesias
  • 13. DIAGNOSTIC APPROACH •First priority is to assess the need for emergency treatment, followed by a comprehensive workup to determine the cause.
  • 15. Trans-tubular potassium gradient (TTKG) : - index reflecting the conservation of potassium in the cortical collecting ducts (CCD) of the kidneys.
  • 16. ECG
  • 17. TREATMENT : The treatment of hyperkalemia is divided into three stages: 1.Immediate antagonism of the cardiac effects of hyperkalemia - Intravenous calcium 2.Rapid reduction in plasma K+ concentration by redistribution into cells • Insulin • β2-agonists (most commonly albuterol) 3. Removal of potassium - using cation exchange resins, diuretics, and/or dialysis. - Hemodialysis is the most effective and reliable method to reduce plasma K+ concentration.
  • 21. Drugs Dosage ONSET Length of MOA effect Cautions Ca2+ gluconate 10 mL of 10% solution IV over 10 minutes Immediate 30 minutes from toxic effects of Ca2+ Protects Can worsen myocardium digoxin toxicity Insulin Regular insulin 10 units IV with 50 mL of 50% glucose 15-30 minutes 2-6 hrs. Shifts K+ out of the vascular space and into the cells Consider 5% Dextrose solution infusion at 100 mL/hr to prevent hypoglycemia with repeated doses. Glucose unnecessary if blood sugar elevated above 250mg/dL Albuterol (Ventolin) 10-20 mg by nebulizer over 10 minutes (use conc. form, 5mg/mL) 15-30 2-3 hrs. minutes Shifts K+ into the cells, additive to the effect of insulin May cause a brief initial rise in serum potassium
  • 22. Drugs Dosage Onset Length of effect MOA Cautions Furosemide (Lasix) 20-40 mg IV, give with saline if volume depletion is a 15 min. - 1 hr. 4 hrs. Increases renal excretion of potassium Only effective if adequate renal response to concern loop diuretic Sodium polystyrene sulfonate (Kayexalate) Oral : 50 g in 30 mL of sorbitol solution Rectal : 50 g in a retention 1-2 hrs. (Rectal route is faster) 4-6 hrs. Removes potassium from the gut in exchange for sodium Sorbitol may be associated with Bowel necrosis. enema